Cost-effectiveness considerations at NICE.
Rawlins
Michael
M
Dillon
Andrew
A
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D015276:Health Care Rationing; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D019057:Quality-Adjusted Life Years; D013222:State Medicine / Q000191:economics*; D006113:United Kingdom